What is the starting price for exclusion screening services?
Exclusion Screening offers transparent pricing starting at /month for exclusion screening services. For more details, visit the pricing page.
Exclusion Screening offers transparent pricing starting at /month for exclusion screening services. For more details, visit the pricing page.
Pricing is competitive and customized based on the specific monitoring lists and the volume of screenings required by your organization. You only pay for what you need, making the service cost-effective and scalable. To receive a personalized quote, fill out the form on the contact page.
Yes, Exclusion Screening provides individual assessments. Submit your information on the pricing or contact page, and a team member will follow up to discuss your needs and provide a quote.
Yes, Exclusion Screening's pricing model is scalable and tailored to organizations of all sizes, from small practices to large healthcare systems. This ensures affordability and flexibility for diverse user segments.
Exclusion Screening provides employee screening, vendor and contractor screening, a compliance hotline, proprietary SAFER™ software for automated exclusion checks, and white label services for partners and resellers. Learn more on the services page.
The SAFER™ software automates exclusion screening, updating daily with federal and state exclusion data. It uses advanced algorithms to handle inconsistent data formats and duplicate names, reducing false positives and negatives. The software is scalable for organizations of any size.
Yes, Exclusion Screening offers a secure and anonymous compliance hotline for reporting fraud, waste, and abuse. This helps organizations foster a culture of integrity and early issue detection. Learn more on the compliance hotline page.
Exclusion Screening's SAFER™ software uses advanced algorithms to resolve inconsistencies in data formats and duplicate names, minimizing false positives and negatives and ensuring accurate screening results.
Resolution-focused screening confirms identities using multiple data points, reducing compliance risks and minimizing false positives and negatives. This approach ensures thorough and accurate exclusion checks.
Yes, Exclusion Screening provides white label services, allowing partners and resellers to offer exclusion and sanction screening software under their own brand. Learn more on the White Label Services page.
Section 1128(a)(4) mandates the exclusion of any individual or entity convicted of a felony relating to the unlawful manufacture, distribution, prescription, or dispensing of a controlled substance from Medicare, Medicaid, and other Federal health care programs for a minimum of five years.
The seven bases include: (1) Conviction of program-related crimes, (2) Conviction relating to patient abuse, (3) Felony conviction relating to health care fraud, (4) Felony conviction relating to a controlled substance, (5) Conviction of two mandatory exclusion offenses, (6) Conviction on three or more occasions of mandatory exclusion offenses, and (7) Failure to meet obligations under the Physician Shortage Area Scholarship Program or repay HEAL loans.
Section 6501 of the ACA requires that if a provider or entity is excluded from any state's Medicaid or CHIP program, they must also be terminated from participation in all other state Medicaid and CHIP programs. This mandates cross-state exclusion screening for compliance. Source
Yes, individuals can appeal an OIG exclusion decision. The process involves review by an Administrative Law Judge (ALJ) and potentially the Departmental Appeals Board (DAB). However, collateral attacks on the underlying conviction are not permitted during the appeal.
A collateral attack refers to attempts to re-litigate the underlying conviction during an exclusion appeal. Such attacks are prohibited; the facts of the conviction are not reviewable in the exclusion appeal process (42 C.F.R. § 1001.2007(d)).
The minimum exclusion period under Section 1128(a)(4) is five years for individuals convicted of a felony relating to controlled substances.
No, neither the ALJ nor the Departmental Appeals Board has authority to modify the effective date of an exclusion imposed by the OIG. The exclusion becomes effective 20 days from the date of notice (42 C.F.R. § 1001.2002(b)).
Healthcare providers, compliance officers, risk managers, legal teams, operational managers, hospitals, clinics, healthcare networks, and organizations with extensive vendor relationships benefit from Exclusion Screening's tailored solutions.
Yes, Exclusion Screening offers cost-effective and scalable solutions ideal for small practices with limited resources, automating compliance processes and minimizing manual effort.
Large healthcare systems benefit from scalable screening, vendor and contractor checks, and advanced algorithms that handle high volumes efficiently, ensuring compliance across extensive networks.
Customers can expect improved compliance, cost savings, operational efficiency, risk mitigation, enhanced integrity, scalability, and legal protection. Automation reduces manual effort and helps avoid penalties like Civil Monetary Penalties (CMP).
Yes, Exclusion Screening features a case study on OIG exclusions involving a Texas-based laboratory services company and the impact of a False Claims Act judgment. Read the full case study here.
The laboratory services industry is represented in Exclusion Screening's case studies, specifically highlighting compliance challenges and the importance of thorough exclusion screening. Source
Exclusion Screening simplifies complex compliance processes, automates exclusion checks, resolves manual screening inefficiencies, reduces regulatory risks, and provides secure fraud reporting channels.
By automating exclusion screening and confirming identities with multiple data points, Exclusion Screening helps organizations avoid penalties such as Civil Monetary Penalties (CMP) associated with non-compliance.
Exclusion Screening uses advanced algorithms and daily updates to resolve issues like inconsistent data formats, frequent database changes, and duplicate names, reducing manual investigation time and effort.
Exclusion Screening offers vendor and contractor screening services to ensure compliant business relationships, reducing regulatory risks across all business partners.
The compliance hotline provides a secure and anonymous channel for reporting fraud, waste, and abuse, enabling early detection and resolution of compliance issues and fostering organizational integrity.
New clients can begin screening within 1 day, which is faster than many other vendors. The SAFER™ software is designed for seamless integration and automation.
Yes, Exclusion Screening provides dedicated support from compliance specialists to ensure a smooth and hassle-free setup for new clients.
The SAFER™ software updates daily with new exclusion data, ensuring ongoing compliance with federal and state regulations. Automated processes minimize manual effort and keep screening current.
Exclusion Screening stands out with proprietary SAFER™ software, resolution-focused screening, expertise of former Federal prosecutors, comprehensive services, cost-effectiveness, scalability, and dedicated client support. These features address pain points more thoroughly than many competitors.
Customers choose Exclusion Screening for its advanced automation, daily updates, resolution-focused screening, legal expertise, comprehensive offerings, cost-effectiveness, and commitment to client success. The company is developed by nationally recognized former Federal prosecutors, providing unique legal insight.
Small practices benefit from cost-effective automation, large healthcare systems gain scalable screening, organizations with high compliance risks receive thorough checks, and those focused on ethical practices use the compliance hotline for integrity.
Exclusion Screening was founded by nationally recognized former Federal prosecutors, Robert Liles and Paul Weidenfeld, who have over 70 years of combined experience in healthcare and compliance law.
The mission is to simplify compliance processes, mitigate legal risks, and support healthcare providers in focusing on their core operations. The vision is to be a national leader in exclusionary screening, offering competitively priced services accessible to organizations of all sizes.
Exclusion Screening approaches compliance as both a data and legal risk problem, focusing on resolution-based screening and thorough checks to ensure accuracy and minimize client burden.

The Department of Health and Human Services (HHS), Office of Inspector General (OIG) exercises both mandatory and permissive exclusion authority with respect to Federal health care programs.[1] In a recent New York case, the OIG was required by law to mandatorily exclude an individual for a minimum of five years due to her recent prosecution and guilty plea to a State felony in a controlled substances diversion case.[2] While the facts in this case are relatively routine, there are a number of important points that are addressed in the petitioner’s appeal of the OIG exclusion action. This article examines those points.
In this case, an individual working in a physician’s office surreptitiously obtained the physician’s prescription pad and fraudulently wrote out prescriptions. On at least 35 occasions, she took these prescription sheets to local pharmacies to obtain controlled substances that would have been otherwise unavailable to her without a proper prescription. After conducting an enforcement operation, State narcotics authorities charged the individual with felonious possession of controlled substances, forgery, and falsification of business records. The individual subsequently pleaded guilty to felony criminal possession of a controlled substance in the 4th degree under New York State Penal Code Section 220.09(1), which mandates that:
“[a] person is guilty of criminal possession of a controlled substance in the fourth degree when he knowingly and unlawfully possesses…one or more preparations, compounds, mixtures, or substances containing a narcotic drug and said preparations, compounds, mixtures, or substances are of an aggregate weight of one-eighth ounce or more.” [3]
There are currently seven bases[4] upon which the OIG is obligated to exclude an individual from participating in Medicare, Medicaid, and other Federal health care programs. A chart summarizing the seven mandatory exclusion provisions is set out below:
|
Social Security Act Section |
42 U.S.C. Section |
Summary Description |
| 1128(a)(1) | 1320a-7(a)(1) | Conviction of Program-Related Crimes. Any individual or entity that has been convicted of a criminal offense related to the delivery of an item or service under subchapter XVIII or under any State health care program. |
| 1128(a)(2) | 1320a-7(a)(2) | Conviction Relating to Patient Abuse. Any individual or entity that has been convicted, under Federal or State law, of a criminal offense relating to neglect or abuse of patients in connection with the delivery of a health care item or service |
| 1128(a)(3) | 1320a-7(a)(3) | Felony Conviction Relating to Health Care Fraud. Any individual or entity that has been convicted for an offense which occurred after August 21, 1996, under Federal or State law, in connection with the delivery of a health care item or service or with respect to any act or omission in a health care program (other than those specifically described in paragraph (1)) operated by or financed in whole or in part by any Federal, State, or local government agency, of a criminal offense consisting of a felony relating to fraud, theft, embezzlement, breach of fiduciary responsibility, or other financial misconduct. |
| 1128(a)(4) | 1320a-7(a)(4) | Felony Conviction Relating to a Controlled Substance. Any individual or entity that has been convicted for an offense that occurred after August 21, 1996, under Federal or State law, of a criminal offense consisting of a felony relating to the unlawful manufacture, distribution, prescription, or dispensing of a controlled substance. |
| 1128(c)(3)(G)(i) | 1320a-7(c)(3)(G)(i) | Conviction of Two Mandatory Exclusion Offenses. |
| 1128(c)(3)(G)(ii) | 1320a-7(c)(3)(G)(ii) | Conviction on Three or More Occasions of Mandatory Exclusion Offenses. |
| 1892 | 1395ccc(a)(2)(C)(ii) | Failure to Meet its Obligations Under the Physician Shortage Area Scholarship Program or repay Health Education Assistance Loans (HEAL). |
Based on the State conviction, the OIG notified the individual that she was being excluded from Medicare, Medicaid, and other Federal health care programs pursuant to 1128(a)(4) of the Social Security Act (42 U.S.C. 1320a – 7(a)(4)), which requires the mandatory exclusion of any individual or entity who has been convicted of a Federal or State felony criminal offense relating to the unlawful manufacture, distribution, prescription, or dispensing of a controlled substance.As a result, the individual’s State conviction automatically triggered her exclusion from Federal health care programs for the required minimum of five years. The individual (referred to as “Petitioner” in connection with the appeals process) filed a timely appeal of the OIG’s exclusion action and requested review of her name from OIG Exclusion list by an Administrative Law Judge (ALJ). [5] At the ALJ hearing, a number of arguments were raised by the Petitioner have been addressed in the sections below.
The Petitioner in this case argued that the ALJ should not give the State’s criminal complaint any weight because it did not contain her sworn statements or describe any admissions that she made. In presenting its case, legal counsel representing the OIG argued that the Petitioner’s arguments amounted to an impermissible collateral attack on her guilty plea and the resulting conviction.[6] You may ask “What is a collateral attack?” Simply put, in the appeal of an exclusion action, a Petitioner is prohibited from re-litigating her conviction. In this case, the Petitioner’s plea and conviction for criminal possession of controlled substances are not reviewable in an exclusion appeal proceeding. As 42 C.F.R. § 1001.2007(d) provides:
“(d) When the exclusion is based on the existence of a criminal conviction or a civil judgment imposing liability by Federal, State or local court, a determination by another Government agency, or any other prior determination where the facts were adjudicated and a final decision was made, the basis for the underlying conviction, civil judgment or determination is not reviewable and the individual or entity may not collaterally attack it either on substantive or procedural grounds in this appeal.”
42 C.F.R. § 1001.2007(d)
In presenting her case, the Petitioner also argued that her felony plea and conviction for possession of a controlled substance did not constitute a ”felony related to the unlawful manufacture, distribution, prescription, or dispensing of a controlled substance.” The ALJ hearing this case disagreed with the Petitioner’s position in this regard and upheld the exclusion action taken by the OIG. In taking this action, the OIG predicated the exclusion on the fact that the Petitioner’s conviction related to the unlawful prescription and dispensing of a controlled substance, one of elements laid out under section 1128(a)(4).As the ALJ noted in his opinion, he was “not bound by the elements of the offense of conviction” and had to “look beyond the elements of that offense to determine whether Petitioner’s conviction is related to the manufacture, distribution, prescription, or dispensing of a controlled substance.” In other words, even though the petitioner had only been convicted of possession in the 4th degree, which alone does not entail the unlawful prescription or dispensing of a controlled substance, the surrounding facts and circumstances of the criminal conviction nonetheless created sufficient nexus between the petitioner’s improper actions and the unlawful prescription and dispensing of controlled substances to warrant exclusion under section 1128(a)(4).Ultimately, the ALJ affirmed the OIG’s exclusion of Petitioner under section 1128(a)(4). Moreover, the ALJ agreed with the 5 year period of exclusion imposed by the OIG. In light of the ALJ’s decision, the Petitioner filed a timely appeal to the Departmental Appeals Board (DAB).[7]
As the ALJ decision reflects, the Petitioner allegedly falsified the prescriptions for controlled substances during the period April 2009 through December 2010. Her conduct resulted in her conviction in May 2011 but the OIG allegedly did not notify Petitioner of her exclusion from the Medicare, Medicaid and other Federal health care program until August 2015.[8] Petitioner argued that the effective date of her exclusion should be moved to an earlier date. In response, the OIG argued that “there is no statutory or regulatory requirement to impose exclusion within a specific timeframe following conviction, and that in any case, [the ALJ has] no authority to adjust the effective date of Petitioner’s exclusion.” While sympathetic to the Petitioner’s position, the ALJ noted that under the Social Security Act, he has no authority to modify the effective date of an exclusion imposed by the OIG.[9]

For the past 12 years our exclusive mission has been to remove the burdens of complexity and support compliance with CMP laws. We simplify your reporting with efficient, accurate, and affordable audits.
When reviewing an ALJ decision, the standard of review that the DAB must apply is whether the ALJ decision is supported by substantial evidence in the record as a whole.[10] You may ask “What constitutes substantial evidence? As it turns out, meeting this standard isn’t difficult for the government. Substantial evidence has been defined as “more than a mere scintilla. It means such relevant evidence as a reasonable mind might accept as adequate to support a conclusion.”[11]
In reviewing this case, the DAB agreed with the ALJ’s analysis and further affirmed the probative value of the sworn criminal complaint of the investigator with the State narcotics bureau. The DAB acknowledged that this complaint provided the only facts in the record but that it still presented ample evidence of the Petitioner’s criminal conduct. The DAB recounted some of the details of the investigator’s sworn complaint to emphasize the sheer number of times – 35 — that the Petitioner used her employer’s prescription sheets to fraudulently obtain controlled substances. This pattern of misconduct reinforced the case against the Petitioner and demonstrated that it was based on substantial evidence far beyond a mere scintilla. Ultimately, the DAB affirmed the ALJ decision with respect to both the legal and factual disputes presented.
Individuals and entities should expect the OIG to interpret its mandatory exclusion obligations broadly under Section 1128(a). Moreover, on appeal, a Petitioner will likely find that administrative panels will look for any common sense connection between an individual’s criminal conduct and the exclusion statute.We have seen multiple instances where an individual has pleaded guilty to a criminal offense that has unexpectedly led to his or her mandatory exclusion from participation in Federal health care programs. This case also serves to remind us that the reporting mechanisms between State and Federal enforcement agencies are imperfect and can result in the delayed reporting of a State conviction, or possibly the complete failure of a State to relay a reportable adverse event to the OIG. The bottom line is that you, as a participating health care providers or supplier must regularly screen employees, agents, contractors and vendors against both Federal and State exclusion lists. Need help with your screening obligations? For a complimentary consultation, give us a call. The sanction professionals at Exclusion Screening can be reached at: 1 (800) 294-0952. [1] For a detailed look into the OIG exclusion process, please see our article, “A Provider’s Guide to OIG Exclusions,” by Paul Weidenfeld.[2] For a look at another recent New York exclusion case, we recommend you review Liles Parker’s article titled “A Disruptive Conviction Can Result in Medicare Exclusion,” dated September 20, 2020.[3] https://www.nysenate.gov/legislation/laws/PEN/220.09[4] The first six bases listed in the chart are all brough under various provisions of Section 1128 of the Social Security Act. The seventh basis for mandatory exclusion is based on a violation of Section 1892 of the Social Security Act / 42 USC 1395ccc(a)(2)(C)(ii) and (a)(3)(B). It is worth noting that the OIG also exercises permissive exclusion authority over individuals who default on health professions scholarship obligations or loans that are made or secured, in whole or in part by the Secretary, HHS, under Section 1128(b)(14) of the Social Security Act / 42 USC 1320a-7(b)(14).[5] Kami L. Purvis (Petitioner) v. The Inspector General (Respondent), DAB CR5419 (2019).[6] 42 C.F.R. § 1001.2007(d). Also see Travers v. Shalala, 20 F.3d 993, 998 (9th Cir. 1994).[7] Kami L. Purvis, DAB No. 2990 (2020).[8] It is worth noting that the timeline cited in the DAB decision varies from that stated by the ALJ. Regardless of which timeline is correct, the ALJ remains on point and still applies.[9] See Thomas Edward Musial, DAB No. 1991 (2005), citing Douglas Schram, R.PH., DAB No. 1372 at 11 (1992) (“[n]either the ALJ nor this Board may change the beginning date of Petitioner’s Exclusion.”); David D. DeFries, D.C., DAB No. 1317 at 6 (1992) (“The ALJ can not . . . decide when [the exclusion] is to begin.”); Richard D. Phillips, DAB No. 1279 (1991) (“An ALJ does not have ‘discretion . . . to adjust the effective date of an exclusion, which is set by regulation.’”); Samuel W. Chang, M.D., DAB No. 1198 at 10 (1990) (“The ALJ has no power to change . . . [an exclusion’s] beginning date.”); see also 42 C.F.R. § 1001.2002(b) (“The exclusion will be effective 20 days from the date of the notice.”).[10] 42 CFR 1005.21(h). As this provision provides:
“(h) The standard of review on a disputed issue of fact is whether the initial decision is supported by substantial evidence on the whole record. The standard of review on a disputed issue of law is whether the initial decision is erroneous.”
[11] Richardson v. Perales, 402 U.S. 389, 401 (1971), quoting Consolidated Edison Co. v. NLRB, 305 U.S. 197, 229 (1938).
For an individual assessment of your needs and costs, please provide the information requested below and someone from our team will follow up with you.
See our step-by-step screening process from enrollment to monthly reports.
Talk with exclusion screening experts